Declaration of Software Validation - Structural validation and Statement of compliance with 21 CFR Part 11

Significance of the Topic

Modern regulated laboratories rely on robust chromatography software to ensure data integrity, regulatory compliance and consistent performance. Software validation under GLP, GMP and FDA 21 CFR Part 11 is critical for quality assurance, enabling organizations to meet stringent industry standards and audit requirements without compromising operational efficiency.

Objective and Overview of the Document

This declaration certifies that Clarity Chromatography Station (version 10.1.00.064) was developed, tested and structurally validated according to a certified quality system. The document serves as a formal statement of compliance with Good Laboratory Practice (GLP), Good Automated Manufacturing Practice (GAMP), Good Manufacturing Practice (GMP), ISO 9001 and FDA 21 CFR Part 11.

Methodology and Instrumentation

The validation process followed the Standard Software Development Life Cycle (SDLC) with defined checkpoints and management approval. Key artifacts available for inspection include:

• Product description and functional specification
• Development and test plans with routines and results
• Revision status records
• Source code documentation

DataApex maintains all documentation on-site and at a secure off-site location, subject to non-disclosure agreements for authorized reviewers.

Main Findings and Discussion

Independent review confirmed that the software meets all functional and performance requirements. Structural validation verified adherence to quality system guidelines throughout the life cycle. Compliance features for FDA 21 CFR Part 11 were demonstrated through:

• Software security controls
• Data integrity mechanisms
• Comprehensive audit trails
• Electronic signature support

Test procedures and data confirm these features operate as intended when configured per the Clarity in Regulated Environment manual (M132).

Benefits and Practical Applications

Validated chromatography software streamlines compliance in pharmaceutical, biotech and food testing laboratories. Key advantages include:

• Regulatory readiness for audits and inspections
• Improved traceability of analytical results
• Reduced risk of data manipulation or loss
• Efficient change control through documented revision history

Future Trends and Opportunities

Emerging developments in analytical software validation may include cloud-based data management with enhanced encryption, integration of artificial intelligence for automated quality checks, and blockchain technology for immutable audit trails. Such innovations can further strengthen data trustworthiness and streamline regulatory compliance processes.

Conclusion

The Declaration of Software Validation for Clarity Chromatography Station provides comprehensive evidence of compliance with international quality standards and FDA 21 CFR Part 11. The documented validation deliverables and certification support regulated laboratories in achieving reliable, compliant chromatographic analyses.